Drug-eluting balloons for coronary artery disease: A meta-analysis of randomized controlled trials

International Journal of Cardiology

Volumn 168, Issue 1, 2013, Pages 197-206

  Yu, Cheuk Man ^a   Kwong, Joey S W ^a   Sanderson, John E ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Coronary artery disease; Drug eluting balloon; Meta analysis; Systematic review

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; LIBERTE; PACLITAXEL; TICLOPIDINE; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; ARTICLE; BALLOON DILATATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING BALLOON; DRUG ELUTING STENT; HEART MUSCLE REVASCULARIZATION; HUMAN; IN-STENT RESTENOSIS; INTERMETHOD COMPARISON; META ANALYSIS; PATIENT SAFETY; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

CORONARY ARTERY DISEASE; DRUG-ELUTING BALLOON; META-ANALYSIS; SYSTEMATIC REVIEW;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84883759853     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.09.094     Document Type: Article

References (46)

1. B. Cortese, and A. Bertoletti Paclitaxel coated balloons for coronary artery interventions: a comprehensive review of preclinical and clinical data Int J Cardiol 161 2012 4 12
2. A.P. Banning, and C.C. Lim Drug-eluting balloons: what is their place on the interventionalist's shelf? Heart 96 2010 1257 1258
3. A. Belkacemi, P. Agostoni, M. Voskuil, P. Doevendans, and P. Stella Drug-eluting balloons in coronary artery disease - current and future perspectives Interv Cardiol 6 2011 157 160
4. M. Zimarino, and R. De Caterina Drug-eluting balloons for percutaneous coronary interventions Thromb Haemost 101 2009 9 11
5. A. Joost, V. Kurowski, and P.W. Radke Drug eluting balloons for the treatment of coronary artery disease: what can we expect? World J Cardiol 2 2010 257 261
6. A. De Labriolle, R. Pakala, L. Bonello, G. Lemesle, M. Scheinowitz, and R. Waksman Paclitaxel-eluting balloon: from bench to bed Catheter Cardiovasc Interv 73 2009 643 652
7. R. Waksman, and R. Pakala Drug-eluting balloon: the comeback kid? Circ Cardiovasc Interv 2 2009 352 358
8. B. Scheller Opportunities and limitations of drug-coated balloons in interventional therapies Herz 36 2011 232 239
9. B. Scheller, U. Speck, C. Abramjuk, U. Bernhardt, M. Böhm, and G. Nickenig Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis Circulation 110 2004 810 814
10. U. Speck, B. Scheller, and C. Abramjuk Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries Radiology 240 2006 411 418
11. B. Cremers, U. Speck, and N. Kaufels Drug-eluting balloon: very short-term exposure and overlapping Thromb Haemost 101 2009 201 206
12. L. Mauri, E.J. Orav, and R.E. Kuntz Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison Circulation 111 2005 3435 3442
13. J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011] The Cochrane Collaboration 2011 [Available from http://www.cochrane-handbook.org (accessed 5 December 2011)]
14. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
15. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman The PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269
16. S. Habara, K. Mitsudo, and K. Kadota Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis JACC Cardiovasc Interv 4 2011 149 154
17. B. Scheller, C. Hehrlein, and W. Bocksch Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter N Engl J Med 355 2006 2113 2124
18. B. Scheller, C. Hehrlein, and W. Bocksch Randomized trial for the treatment of in-stent restenosis by a paclitaxel coated balloon catheter - PACCOCATH ISR Eur Heart J 26 2005 415
19. B. Scheller, C. Hehrlein, and W. Bocksch 12 month follow up of a randomized trial for the treatment of in-stent restenosis by a paclitaxel coated balloon catheter - PACCOCATH ISR Eur Heart J 27 Suppl. 1 2006 581 582
20. B. Scheller, C. Hehrlein, and W. Bocksch Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter Clin Res Cardiol 97 2008 773 781
21. B. Scheller, C. Hehrlein, and W. Bocksch Treatment of in-stent restenosis by a paclitaxel coated balloon catheter: PACCOCATH ISR II trial Circulation 114 2006 2427
22. M. Unverdorben, C. Vallbracht, and B. Cremers Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis Circulation 119 2009 2986 2994
23. S. Rosenkranz, L.S. Maier, C. Maack, and M. Böhm Hotline update of clinical trials and registries presented at the German Cardiac Society Meeting 2007: 2L-Registry, Kardio-Pro, EVER, AFFECT, VTACH, ARTS II, OPTAMI, PEPCAD I, PEPCAD II, GERSHWIN, SPICE, FIX-CHF and CREDIT Clin Res Cardiol 96 2007 457 468
24. L.S. Maier, C. Maack, O. Ritter, and M. Böhm Hotline update of clinical trials and registries presented at the German Cardiac Society meeting 2008. (PEPCAD, LokalTax, INH, German ablation registry, German device registry, DES.DE registry, DHR, Reality, SWEETHEART registry, ADMA, GERSHWIN) Clin Res Cardiol 97 2008 356 363
25. J. Wöhrle Prospective randomized study for the treatment of coronary in-stent restenosis by the paclitaxel-eluting balloon catheter SeQuent Please vs. the Taxus Stent Herz 33 2008 462
26. Y.P. Clever, S. Rosenkranz, M. Böhm, and B. Scheller Hotline update of clinical trials and registries presented at the ACC and SCAI-ACCi2 meeting 2008 in Chicago Clin Res Cardiol 97 2008 409 417
27. B. Cortese, A. Micheli, and A. Picchi Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study Heart 96 2010 1291 1296
28. B. Cortese The PICCOLETO study and beyond EuroIntervention 7 Suppl. K 2011 K53 K56
29. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization Eur Heart J 31 20 2010 2501 2555
30. P.R. Stella, A. Belkacemi, and P. Agostoni Drug-eluting balloons and bifurcations, a new future? EuroIntervention 6 Suppl. J 2010 J161 J164
31. A. Belkacemi, P. Agostoni, M. Voskuil, and P.R. Stella Coronary bifurcation lesions treated with the drug-eluting balloon: a preliminary insight from the DEBIUT study EuroIntervention 7 Suppl. K 2011 K66 K69
32. A. Belkacemil, P. Agostoni, and C. Dubois 6-month angiographic and 18-month clinical results of the multicenter randomized DEBIUT (Drug Eluting Balloon In BIfUrcations Trial) J Am Coll Cardiol 58 2011 B6
33. B. Claessen, J.P.S. Henriques, J.C. George, and G.D. Dangas Society for Cardiovascular Angiography and Interventions 2010 and EuroPCR 2010: an update in interventional cardiology JACC Cardiovasc Interv 3 2010 882 884
34. NCT00857441 Drug-eluting Balloon in Bifurcations Trial (DEBIUT) http://clinicaltrials.gov/ct2/show/NCT00857441 [accessed 7 December 2011]
35. NCT01278186 Study of the Paclitaxel-Coated Balloon Catheter in Bifurcated Coronary Lesions (BABILON) http://clinicaltrials.gov/ct2/show/NCT01278186 [accessed 7 December 2011]
36. NCT01127958 DARE-trial: a trial studying the effect of the SeQuent Please drug-eluting balloon compared to the Xience Prime drug-eluting stent for the treatment of stenosis of an earlier implanted stent http://clinicaltrials.gov/ ct2/show/NCT01127958 [accessed 7 December 2011]
37. NCT01093300 Comparison of the efficacy of paclitaxel-releasing balloon catheter system versus the everolimus-eluting stent system for treatment of in-stent restenosis lesions - harmonizing optimal strategy for treatment of in-stent restenosis lesions (The HOST-ISR trial) http://clinicaltrials.gov/ct2/ show/NCT01093300 [accessed 7 December 2011]
38. NCT00987324 Efficacy study of paclitaxel-eluting balloon, -stent vs. plain angioplasty for drug-eluting stent restenosis (ISAR-DESIRE-3) http://clinicaltrials.gov/ct2/show/NCT00987324 [accessed 7 December 2011]
39. NCT01180517 The paclitaxel-eluting percutaneous coronary angioplasty (PTCA)-balloon catheter for the treatment of coronary bifurcations (PEPCAD-BIF) http://clinicaltrials.gov/ct2/show/NCT01180517 [accessed 7 December 2011]
40. NCT01084408 Efficacy of the SeQuent®Please in the treatment of de-novo stenoses versus Taxus™Liberté™ (PEPCAD-DEBonly) http://clinicaltrials.gov/ct2/show/NCT01084408 [accessed 7 December 2011]
41. NCT00998439 Treatment of drug-eluting stent (DES) in-stent restenosis with SeQuent® Please paclitaxel eluting percutaneous transluminal coronary angioplasty (PTCA) catheter http://clinicaltrials.gov/ct2/show/NCT00998439 [accessed 7 December 2011]
42. NCT01489449 Bare metal stent versus drug coated balloon with provisional stenting in non-ST-elevation myocardial infarction (PEPCADNSTEMI) http://clinicaltrials.gov/ct2/show/NCT01489449 [accessed 7 December 2011]
43. NCT01255956 Restenosis treatment with rapamycin eluting stent or paclitaxel eluting balloon catheter (RESTENOZA) (ISRII) http://clinicaltrials. gov/ct2/show/NCT01255956 [accessed 7 December 2011]
44. NCT01239940 RIBS IV (restenosis intra-stent of drug-eluting stents: paclitaxel-eluting balloon vs everolimus-eluting stent) http://clinicaltrials. gov/ct2/show/NCT01239940 [accessed 7 December 2011]
45. NCT01239953 RIBS V (restenosis intra-stent of bare metal stents: paclitaxel-eluting balloon vs everolimus-eluting stent) http://clinicaltrials. gov/ct2/show/NCT01239953 [accessed 7 December 2011]
46. NCT01065532 SEDUCE OCT study in coronary artery restenosis: an optical coherence tomography (OCT) study http://clinicaltrials.gov/ct2/show/NCT01065532 [accessed 7 December 2011]